Nigeria is expected to receive 176,000 doses of the Johnson and Johnson COVID-19 vaccines on Wednesday.
Executive Director, National Primary Health Care Development Agency, Faisal Shuaib, confirmed this at a news conference in Abuja on Tuesday.
He said the J&J vaccine, like the AstraZeneca, is safe and efficient against the coronavirus disease, including the deadlier Delta Variant.
The J&J vaccine is a single-shot vaccine.
Speaking further, Shuaib debunked reports that the delay in the commencement of the second batch of the COVID-19 inoculation exercise is owing to cases of propriety.
Details later…
